SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Climb Bio Q3'26 Results Scheduled for Nov. 11

Climb Bio is expected to report Q3'26 results on November 11. Revenue is estimated at zero, with EPS anticipated at negative 0.20.

CLYM

CLYM (Climb Bio, Inc.) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.20) USD. Learn more details at CLYM Financials…

Related stories